OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data
<p>Trigeminal neuralgia (TN) patients may develop side effects from centrally acting drugs, have contraindications for neurosurgical procedures, or experience relapse during conventional therapies. OnabotulinumtoxinA (BoNT/A) has been reported to be effective for TN, although this finding has...
Saved in:
| Main Authors: | Pedro A. Kowacs, Marco A. T. Utiumi, Fábio A. Nascimento, Elcio J. Piovesan, Helio A. G. Teive |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2015-01-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015005050109&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum neurotoxin type-A when utilized in animals with trigeminal sensitization induced a antinociceptive effect
by: Elcio J Piovesan, et al.
Published: (2016-06-01) -
Botulinum toxin type-A effect as a preemptive treatment in a model of acute trigeminal pain: a pre-clinical double-blind and placebo-controlled study
by: Elcio Juliato Piovesan, et al.
Published: (2011-02-01) -
Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated
by: Jean Pierre Mette Batisti, et al. -
Toxina botunílica tipo B no manejo de distonia não-responsiva a toxina botunílica tipo A
by: Francisco Cardoso
Published: (2003-09-01) -
Evaluación de la eficacia de la toxina botulínica tipo a vía intramuscular en los músculos masticatorios para el tratamiento del dolor orofacial.
by: Marlledith Alejandra Cáceres Rodríguez, et al.
Published: (2024-12-01)